Revisiting nuclear grade as a high-risk marker for predicting upgrade in ductal carcinoma in situ. - Ueki Y; Horimoto Y; Harada K; Ushiyama Y; Nozaki Y; Ishizuka Y; Semba R; Uenaka N; Kawate T; Ushigusa T; Sato E; Onagi H; et al. (Human pathology, 2026)